Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial-Reference-Cited by-同舟云学术

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

Published:2009-04 Issue:9671 Volume:373 Page:1253-1263
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Reid David M,Devogelaer Jean-Pierre,Saag Kenneth,Roux Christian,Lau Chak-Sing,Reginster Jean-Yves,Papanastasiou Philemon,Ferreira Alberto,Hartl Florian,Fashola Taiwo,Mesenbrink Peter,Sambrook Philip N

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study;Walsh;BMJ,1996

2. Use of oral corticosteroids and risk of fractures;van Staa;J Bone Miner Res,2000

3. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses;van Staa;Rheumatology (Oxford),2000

4. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis;van Staa;Osteoporos Int,2002

5. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update;Arthritis Rheum,2001

Cited by 440 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic glucocorticoid therapy for SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis;PAIN, JOINTS, SPINE;2024-09-08

3. Bone targeted nano-drug and nano-delivery;Bone Research;2024-09-04

4. Change in body temperature, not acute-phase reaction, predict anti-Osteoporosis efficacy after the first administration of Zoledronic acid: a prospective observational cohort study;BMC Musculoskeletal Disorders;2024-09-02

5. Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice;Drugs & Therapy Perspectives;2024-07-18